1706 completed. 1706 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1706 | Completed 1706 |
Follow Endocrine System Diseases: new trials by email Literature Review of Endocrine System Diseases trials Research Report on Endocrine System Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized, Controlled Study to Investigate the 12-month Efficacy and Safety of Resveratrol Vitamin Supplements in Patients With Non-proliferative Diabetic Retinopathy Without Center Involved Diabetic Macular Edema (REVOLUTION Study) Resveratrol-Containing Vitamin Supplement - Diabetic Retinopathy, Non Proliferative Diabetic Retinopathy | Phase 4 | Completed | University of Athens | 100 | 2026-09-30 | 2026-10-09 |
| Effects of Metformin and Theory-Based Education in Women With Polycystic Ovary Syndrome MetFORMIN, Matching Placebo, Theory-Based Behavioral Educational Program - Polycystic Ovary Syndrome (PCOS) Women | Phase 4 | Completed | Jerash Private University | 900 | 2026-08-01 | 2026-09-10 |
| Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard Anesthesia Iheezo, Lidocaine pledget - Macular Degeneration, Diabetic Retinopathy | Phase 4 | Completed | Retina Consultants of Delmarva | 50 | 2026-05-20 | 2026-08-21 |
| THE EFFECT OF LUMBRICUS RUBELLUS DLBS1033 EXTRACT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Oral Lumbricus Rubellus DLBS1033 (Low Dose), Oral Lumbricus Rubellus DLBS1033 (High Dose), Standard Diabetes Mellitus Therapy - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Universitas Sebelas Maret | 60 | 2026-03-01 | 2026-07-06 |
| Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol Rosuvastatin + Ezetimibe, Bempedoic Acid + Ezetimibe, Rosuvastatin + Ezetimibe + Bempedoic Acid - Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol | Phase 4 | Completed | Bahria University | 126 | 2026-01-01 | 2026-10-20 |
| A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL DermaBind TL - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU) | Phase 4 | Completed | HealthTech Wound Care | 150 | 2025-12-10 | 2026-10-30 |
| Levothyroxine Dosing in Neonatal Congenital Hypothyroidism Levothyroxine - Congenital Hypothyroidism | Phase 4 | Completed | Menoufia University | 101 | 2025-11-02 | 2026-08-10 |
| Efficacy of NOSHINtrial in Diabetic Patients anti-diabetic herbal drug - Diabetes Mellitus, Type 2, Insulin Resistance | Phase 4 | Completed | Kerman Medical University | 70 | 2025-09-26 | 2026-08-10 |
| Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic Foot Intraosseous Vancomycin, Intravenous Vancomycin - Diabetic Foot Disease, Diabetic Foot Infection | Phase 4 | Completed | Başakşehir Çam & Sakura City Hospital | 40 | 2025-08-06 | 2026-07-10 |
| Metformin Effects on Metabolic, Vitamin B12, Iron, Erythropoietin, and Hematological Parameters in Women With PCOS Metformin, Matching Placebo - Polycystic Ovary Syndrome (PCOS) Women | Phase 4 | Completed | Jerash Private University | 400 | 2025-08-01 | 2026-08-31 |
| The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity Empagliflozin (oral), Dapagliflozin (DAPA), Metfomin - Type 2 Diabetes, Obese Diabetics | Phase 4 | Completed | Erbil Polytechnic University | 260 | 2025-07-15 | 2026-03-17 |
| Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC) Amnion-Intermediate-Chorion, Standard of Care (SOC) - Diabetic Foot Ulcer | Phase 4 | Completed | Cellution Biologics | 84 | 2025-07-03 | 2026-08-20 |
| Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission Contrave ER, Low-calorie meal box - Diabetes, Type 2, Obesity &Amp; Overweight | Phase 4 | Completed | Yeouido St. Mary's Hospital | 25 | 2025-07-01 | 2026-08-07 |
| Comparison of Clomiphene Alone Versus Clomiphene Plus Sildenafil for Ovulation in Women With Polycystic Ovary Syndrome Clomiphene Citrate 100 mg, Sildenafil Citrate 25Mg Tab, Placebo - Polycystic Ovarian Syndrome (PCOS), Polyendocrine Metabolic Ovarian Syndrome (PMOS) | Phase 4 | Completed | Nishtar Medical University | 98 | 2025-07-01 | 2026-08-18 |
| Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes Empagliflozin, Metformin - Type 2 Diabetes Mellitus, Hypertension | Phase 4 | Completed | Dr. Zarmina Younes | 300 | 2025-06-09 | 2026-04-21 |
| Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol | Phase 4 | Completed | Nishtar Medical University | 60 | 2025-06-01 | 2026-07-14 |
| Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. Metformin, Dulaglutide, Semaglutide 1.0 mg - Diabetes Mellitus Type 2 | Phase 4 | Completed | Fundación para la Investigación del Hospital Clínico de Valencia | 92 | 2025-05-26 | 2026-09-04 |
| Randomized Transition to Gla-300 in Pediatric Type 1 Diabetes: CGM-Derived Outcomes Insulin glargine U-300 - Type 1 Diabetes Mellitus | Phase 4 | Completed | Marmara University | 71 | 2025-05-01 | 2026-10-13 |
| Adding SGLt2 Inhibitors to Patients With Type 2 Diabetes SGLT2 inhibitor - Type 2 Diabetes | Phase 4 | Completed | Assiut University | 482 | 2025-04-01 | 2026-09-10 |
| A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus iGlarLixi (insulin glargine/lixisenatide) - Type 2 Diabetes | Phase 4 | Completed | Sanofi | 105 | 2025-01-06 | 2026-07-10 |
Showing 20 of 1706. Sign in to see all of them.
Diabetes Mellitus, Type 2 (803) · Diabetes Mellitus (493) · Diabetes Mellitus, Type 1 (140) · Insulin Resistance (115) · Hypertension (76) · Polycystic Ovary Syndrome (72) · Obesity (67) · Coronary Artery Disease (51) · Hypogonadism (43) · Diabetic Nephropathies (41) · Hyperglycemia (37) · Diabetic Neuropathies (34) · Hyperparathyroidism, Secondary (34) · Renal Insufficiency, Chronic (31) · Cardiovascular Diseases (30)
Nutritional and Metabolic Diseases (1301) · Metabolic Diseases (1275) · Glucose Metabolism Disorders (1243) · Diabetes Mellitus (841) · Urogenital Diseases (282) · Female Urogenital Diseases and Pregnancy Complications (261) · Cardiovascular Diseases (255) · Pathological Conditions, Signs and Symptoms (250) · Female Urogenital Diseases (247) · Vascular Diseases (225) · Gonadal Disorders (171) · Immune System Diseases (171) · Autoimmune Diseases (162) · Male Urogenital Diseases (162)
Metformin (200) · Insulin Glargine (171) · Sitagliptin Phosphate (82) · dapagliflozin (69) · Insulin Aspart (67) · Insulin (65) · Pioglitazone (54) · Liraglutide (50) · Insulin Lispro (44) · Exenatide (43) · glimepiride (43) · Insulin Detemir (42) · Vildagliptin (42) · empagliflozin (41) · insulin aspart, insulin aspart protamine drug combination 30:70 (39)
Sanofi (91) · Novo Nordisk A/S (84) · Eli Lilly and Company (37) · Novartis Pharmaceuticals (28) · AstraZeneca (26) · Emory University (20) · GlaxoSmithKline (20) · Takeda (15) · The University of Texas Health Science Center at San Antonio (15) · Steno Diabetes Center Copenhagen (14) · University of Colorado, Denver (14) · Boehringer Ingelheim (13) · Novartis (13) · Amgen (12) · Gulhane School of Medicine (12)
United States (477) · China (130) · South Korea (116) · Denmark (100) · Germany (96) · Italy (93) · United Kingdom (92) · Canada (82) · France (80) · Spain (70) · Sweden (61) · Brazil (60) · Netherlands (57) · India (55) · Mexico (54)
Guillermo Umpierrez, MD (12) · Stefano Palomba, MD (7) · Herbert B Slade, MD (6)
PMID 33166419, PMID 39963952, PMID 37435938, PMID 38682786, PMID 32501595, PMID 35224730, PMID 34693515, PMID 38770818, PMID 40875095, PMID 15613435, PMID 15827109, PMID 17513708, PMID 19156705, PMID 19366972, PMID 19454394, PMID 20536957, PMID 20923490, PMID 21228246, PMID 22002075, PMID 22775317, PMID 23435159, PMID 23857221, PMID 27529295, PMID 27611736, PMID 28143456, PMID 30084288, PMID 30206821, PMID 30521533, PMID 30779243, PMID 31802967, PMID 31865758, PMID 32803882, PMID 33210751, PMID 33293204, PMID 35322793, PMID 36262060, PMID 37752566, PMID 38449081, PMID 39641307, PMID 39735417, PMID 10469005, PMID 10517721, PMID 10518081, PMID 10599727, PMID 10599729, PMID 10683005, PMID 10690849, PMID 10768918, PMID 10898438, PMID 10999798
2015 (16), 2014 (10), 2008 (8), 2009 (8), 2016 (8), 2019 (5), 2005 (4), 2017 (4), 2018 (3), R01DK077166 (2), R01DK107680 (2), U54RR014616 (2), 2025 (1), I01CX001665 (1), K12HD001259 (1)